Skip to main content

Table 2 Quality of reporting of included studies

From: A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases

First author and publication year

Country

1. Was there an adequate description of study design?

2. Was there an adequate description of eligibility criteria?

3. Is the study population representative of the target population?

4. Is there an adequate description of outcomes?

5. Is there an adequate description of the study participants?

Overall assessment

Meikle 1999 [31]

Australia

Yes

Yes

Yes

No

No

Medium

Lowry 1990 [41]

Canada (BC)

No

Unclear

Yes

No

No

Low

Lowry 1971 [40]

Canada (BC)

No

Unclear

Unclear

No

No

Low

Applegarth 2000 [30]

Canada (BC)

Yes

Yes

Yes

Yes

No

Medium

Nelson 2003 [18]

Australia (W)

Yes

No

Yes

Yes

No

Medium

Gomez 2012 [39]

Colombia (B&C)

Yes

No

Yes

Yes

No

Medium

Malm 2008 [33]

Denmark

No

Unclear

Yes

Yes

No

Low

Baehner 2005 [32]

Germany

Yes

Yes

Yes

No

No

Medium

Poorthuis 1999 [37]

Netherlands

Yes

Unclear

Yes

Yes

No

Medium

Moammar 2010 [34]

Saudi Arabia

Yes

Unclear

No

Yes

No

Low

Lin 2009 [38]

Taiwan

Yes

Unclear

Yes

No

No

Low

Al-Jasmi 2010 [25]

UAE

Yes

Unclear

Yes

Yes

No

Medium

Nelson 1997 [17]

UK (NI)

Yes

Unclear

Yes

No

No

Low

  1. Abbreviations: BC British Columbia, B&C Boyacá and Cundinamarca, NI Northern Ireland, UAE United Arab Emirates, UK United Kingdom.
  2. Quality assessment was based on the checklist in Additional file 2.